Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-14.67M
↓ 63% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-8.99M
Historical baseline
PeriodValueYoY Change
TTM$-14.67M-33.9%
2024$-10.96M-43.6%
2023$-7.63M-182.5%
2022$-2.70M-